Key result
Mianserin avoids the heart rate and PR interval increases seen with amitriptyline.
Why the study?
The cardiac effects of mianserin compared to amitriptyline in the treatment of depressive illness were not well characterized.
Does mianserin have fewer cardiotoxic ECG effects than amitriptyline in female patients with depressive illness?
RCT (n=27)
Double-blind
Does mianserin have fewer cardiotoxic ECG effects than amitriptyline in female patients with depressive illness?
Mianserin lacks the cardiotoxic effects (increased heart rate and PR interval) seen with amitriptyline after 3 weeks of treatment in depressed female patients.
Answers are grounded in this paper and cite their sources.
Mianserin may be preferred over amitriptyline when ECG safety is a concern; confirms differential cardiotoxicity in this RCT of depressed women.
In the course of a double-blind comparative trial of mianserin versus amitriptyline in the treatment of depressive illness, E.C.G. was recorded before and after three weeks of treatment in 27 female patients. Mianserin had no consistent effect on heart rate, PR interval, QRS width, or T wave amplitude. This is consistent with other data suggesting that mianserin lacks cardiotoxic effects. In contrast, amitriptyline treatment was associated with increases in heart rate and PR interval, and these effects were statistically significant in comparison to the mianserin group. This finding is consistent with the known cardiotoxicity of amitriptyline. Zusammenfassung Bei einer doppeltblinden, vergleichenden Versuchsserie mit Mianserin und Amitriptylin zur Behandlung depressiver Erkrankungen wurde das EKG vor und nach 3wöchiger Behandlung von 27 Patientinnen verglichen. Mit Mianserin wurde keine gleichmäßige Wirkung auf Pulszahl, PR-Dauer, QRS-Breite oder auf die T-Wellenhöhe beobachtet, entsprechend anderen Ergebnissen, nach denen eine kardiotoxische Wirkung von Mianserin nicht nachzuweisen sei. Dagegen wurden bei Behandlung mit Amitriptylin gesteigerte Pulszahl und PR-Dauer festgestellt – Befunde, die im Vergleich zur Mianserin-Gruppe statistisch signifikant waren. Die bekannte Kardiotoxizität von Amitriptylin wurde durch diesen Befund bestätigt.
No takes yet. Share an insight, caveat, or question.
Peet et al. (1977) conducted an RCT in depressive illness (n=27). Mianserin vs. Amitriptyline was evaluated on Changes in E.C.G. parameters (heart rate, PR interval, QRS width, T wave amplitude). Mianserin lacked cardiotoxic effects on ECG parameters, whereas amitriptyline significantly increased heart rate and PR interval compared to mianserin after three weeks of treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: